To examine sources of variance in objectively measured physical activity and to determine the number of monitoring days needed to quantify physical activity patterns reliably, 394 Flemish adults (41.1 ± 9.9 years) were monitored during 7 days, using the SenseWear Armband. Differences between weekdays, Saturday and Sunday were examined with repeated measures ANOVA's. Variance components were estimated for subject, weekday and residual error using data from Mondays through Fridays and used to calculate the reliability of 1-5 monitoring weekdays. Saturday was more and Sunday less active than an average weekday. Inter-individual variability was the largest source of variance (54.4-67.9%) for physical activity level (PAL), energy expenditure, inactivity, light, moderate and total physical activity. Intra-individual variability accounted for 31.8-44.8% and weekday for 0.1-1.1% of total variance. Intra-individual variability was the largest source of variance for vigorous activity in both sexes and steps in women. At least, 3 monitoring weekdays were required to achieve a reliability of 0.80 for PAL, energy expenditure, inactivity, light, moderate and total physical activity. All 5 weekdays should be monitored to reach acceptable reliability for steps. Five weekdays resulted in a reliability of 0.58-0.60 for vigorous activity. Both Saturday and Sunday and at least 3 weekdays need to be monitored to obtain reliable measures of habitual physical activity.
Engagement in MVPA may be essential to prevent MetS and individual risk factors.
IntroductionTraditionally, assessment in axial Spondyloarthritis (aSpA) includes the evaluation of the capacity to execute tasks, conceptualized as physical function. The role of physical activity, defined as movement-related energy expenditure, is largely unknown and almost exclusively studied using patient-reported outcome measures. The aims of this observational cross-sectional study are to compare physical activity between patients with aSpA and healthy controls (HC) and to evaluate the contribution of disease activity to physical activity differences between groups.MethodsForty patients with aSpA were matched by age, gender, period of data acquisition in terms of days and season to 40 HC. Physical activity was measured during five consecutive days (three weekdays and two weekend days) using ambulatory monitoring (SenseWear Armband). Self-reported disease activity was measured by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Differences in physical activity between patients with aSpA and HC were examined with Wilcoxon signed-rank tests and a mixed linear model. Difference scores between patients and HC were correlated with disease activity.ResultsAverage weekly physical activity level (Med(IQR); HC:1.54(1.41–1.73); aSpA:1.45(1.31–1.67),MET) and energy expenditure (HC:36.40(33.43–41.01); aSpA:34.55(31.08–39.41),MET.hrs/day) were significantly lower in patients with aSpA. Analyses across intensity levels revealed no significant differences between groups for inactivity and time spent at light or moderate physical activities. In contrast, weekly averages of vigorous (HC:4.02(1.20–12.60); aSpA:0.00(0.00–1.20),min/d), very vigorous physical activities (HC0.00(0.00–1.08); aSpA:0.00(0.00–0.00),mind/d) and moderate/(very)vigorous combined (HC2.41(1.62–3.48); aSpA:1.63(1.20–2.82),hrs/d) were significantly lower in patients with aSpA. Disease activity did not interact with differences in physical activity between patients with aSpA and HC, evidenced by non-significant and very low correlations (range: −0.06–0.17) between BASDAI and HC-aSpA patients' difference scores.ConclusionsPatients with aSpA exhibit lower physical activity compared to HC and these differences are independent of self-reported disease activity. Further research on PA in patients with aSpA should be prioritized.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.